BRA Day is an initiative designed to promote education, awareness and access for women who may wish to consider post-mastectomy breast reconstruction.
Anaplastic Large Cell Lymphoma (ALCL)
In January 2011, the American Food and Drug Administration (FDA) issued a communication to inform health care providers and the public about a possible association between breast implants and a type of anaplastic large cell lymphoma (ALCL).
Information published by the FDA is available in the following web pages:
Further information from the Canadian Society of Plastic Surgeons:
ALCL Letter to CSPS Membership (December 3, 2019)
ALCL Letter to CSPS Membership (August 12, 2019)
ALCL Letter to CSPS Membership (July 30, 2019)
ALCL Letter to CSPS Membership (May 30, 2019)